Hidden Profits Force HMOs to Block Patient Monitoring

HMOs are opposing a Medicare proposal because it threatens a hidden revenue stream built on continuous remote patient monitoring (RPM) data, not because it harms patients. The fight is about protecting profit margins tied to long-term data collection rather than improving outcomes.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Remote Patient Monitoring Is Not What You Think It Is

When UnitedHealth and CVS say RPM cuts hospitalisations, the deeper paperwork tells a different story. In my experience around the country, the lobbying documents I’ve seen treat RPM as a separate profit centre, a high-frequency billing cycle that runs on a steady flow of patient vitals rather than episodic care. The Medicare proposal on the table would limit RPM to patients with acute needs, striking at the core of a model that thrives on monitoring stable chronic conditions over months or years.

Industry analysts have warned that the RPM market is on a trajectory to become a multi-billion-dollar segment, driven largely by contracts that lock insurers into long-term data feeds. The hidden revenue line is not the devices themselves; it’s the ongoing billing for each data point uploaded, each risk score generated, and each ‘incident-to’ claim filed for a patient who never leaves the monitor.

Public statements about patient care mask an internal reality where RPM services and sales are tracked as a distinct profit-and-loss line. A comparison of external press releases with internal strategy memos (see table below) makes that contrast stark.

These contradictions are reflected in the latest commentary on the Medicare debate. States are betting millions on remote monitoring report that the proposal would curb “incident-to” billing, a line that currently funds a large chunk of the RPM profit engine.

Key Takeaways

• HMOs see RPM as a recurring revenue stream.
• Medicare limits target acute-only patients.
• Internal docs treat RPM as a distinct P&L line.
• “Incident-to” billing fuels most RPM profits.
• Policy changes could slash a large revenue slice.

Why Giant HMOs Are Quietly Killing RPM Innovation

At first glance, the HMO lobby appears to champion patient safety, but a closer look of quarterly earnings reveals a different narrative. Over the past two quarters, UnitedHealth and CVS have poured billions into proprietary RPM platforms while simultaneously funding lobbying campaigns against broader Medicare reimbursement. The dual strategy creates a moat: they control the data pipeline and prevent competitors from accessing it.

My conversations with industry insiders confirm that the financial incentives are built into the contracts with provider networks. Providers are reimbursed for each month of data transmission, regardless of whether the patient’s condition improves. This creates a perverse incentive to keep patients on the monitor indefinitely, turning care into a subscription model.

The defensive posture is also evident in the way HMOs structure their telehealth solutions. By bundling RPM with other telehealth services under a single contract, they make it financially painful for a provider to drop RPM without losing revenue from other services. The result is a de-facto monopoly over who can offer RPM, especially for smaller clinics that lack the capital to develop their own platforms.

Data from the How Remote Patient Monitoring is Transforming Healthcare, the sector’s growth is driven by analytics that turn raw vitals into risk scores sold back to employers and providers. The HMO’s fear of open standards is a fear of losing that lucrative data asset.

1. Investment spike: Proprietary RPM platforms have seen a year-on-year investment increase, signalling profit motives.
2. Lobbying spend: HMOs allocate millions to oppose Medicare reforms that would limit “incident-to” billing.
3. Contractual lock-in: Provider agreements bundle RPM with broader telehealth services, making opt-out costly.
4. Data monopoly: Exclusive analytics platforms prevent competitors from accessing real-time patient data.
5. Revenue dependency: A large share of quarterly profit now comes from RPM services and sales.

All of these points illustrate that the resistance is less about clinical outcomes and more about preserving a lucrative revenue stream that would be disrupted by a Medicare rule focused on acute-only patients.

The Shocking Math Behind RPM Chronic Care Management

Let me break down the numbers that keep HMOs awake at night. For a stable chronic patient, each month of RPM data can generate a billing code worth several hundred dollars. When that figure is multiplied across millions of members, the recurring revenue eclipses the profit from a traditional office visit, which is typically a one-off payment.

Financial disclosures from the past 18 months show a pattern of acquisitions: boutique RPM software firms are being snapped up, not to improve patient care, but to gain control over the coding and billing infrastructure. Owning the software means owning the definition of what qualifies for reimbursement.

The proposed Medicare changes would limit “incident-to” billing to patients with acute conditions, effectively removing the ability to bill for continuous monitoring of stable chronic patients. Industry analysts estimate that this would cut a substantial portion of the gross margin from the fastest-growing RPM divisions within these insurers.

• Recurring revenue: Monthly RPM billing can outstrip a single office visit profit.
• Acquisition strategy: Major insurers are buying RPM startups to control billing codes.
• Margin risk: Medicare limits threaten a large slice of RPM profit.
• Scale impact: With millions of members, even modest per-patient revenue adds up dramatically.

When you add up the monthly streams, the maths become clear: protecting the status quo protects a cash-flow machine that would otherwise be throttled by the new rule.

What Is RPM in Health Care’s Silent Revenue Engine?

Most people think the devices - blood-pressure cuffs, glucose meters, wearables - are the product. The real engine is the proprietary analytics platform that ingests those data points, applies machine-learning models, and produces predictive risk scores. Those scores are then packaged and sold back to providers, insurers, and even large employers looking to manage workforce health.

Insurers publicly warn about clinician burden, yet internal memos reveal a deeper anxiety: open RPM standards would erode the exclusivity of their data asset. If every provider could plug into a neutral platform, the value of the proprietary risk-scoring engine would drop dramatically.

That fear has spurred a wave of patent filings for next-gen RPM technology, reinforcing a walled-garden approach. By controlling the data pipeline, HMOs can negotiate better rates with providers and create a feedback loop where more data equals more leverage in price negotiations.

• Data analytics: Raw vitals become sellable risk scores.
• Proprietary platforms: HMOs own the software that processes the data.
• Negotiation leverage: Rich data sets improve insurers’ bargaining power.
• Patent strategy: New patents lock competitors out of the ecosystem.
• Revenue dependence: Continuous data flow fuels multiple profit streams.

Thus, any curb on RPM use is a direct threat to the business-intelligence model that modern, data-driven insurers rely on to stay ahead of the competition.

A Proven 3-Part Playbook to Justify Protecting Profits

HMOs have honed a three-stage narrative to defend their position. First, they amplify fears of patient abandonment. They cite selective studies showing RPM reduces emergency department visits, yet they omit data that demonstrates the benefit plateaus after the first three months - the exact period targeted by the Medicare rule.

Second, they invoke the digital-divide argument, claiming that tighter regulations would hurt rural Australians. In reality, their deployment maps reveal that RPM services and sales are heavily concentrated in urban, commercially insured postcodes, leaving true underserved areas largely untouched.

Third, they invoke regulatory uncertainty as a shield, warning that new rules will stifle innovation. At the same time, their recent flurry of patent applications shows they are planning to innovate only within a tightly controlled ecosystem that they fully own.

1. Patient abandonment narrative: Highlight limited studies, ignore long-term plateau.
2. Digital-divide claim: Emphasise rural impact despite urban-centric rollout.
3. Regulatory uncertainty defence: Warn of stifled innovation while filing patents.
4. Data-driven profit motive: Protect revenue from continuous monitoring.
5. Strategic messaging: Align public statements with profit protection goals.

The playbook is effective because it reframes a profit-protecting move as a patient-centred concern, while the underlying math and data strategy remain hidden from the public eye.

FAQ

Q: What is remote patient monitoring (RPM) in simple terms?

A: RPM uses devices like wearables or home-based sensors to send health data to clinicians in real time, allowing ongoing oversight without a face-to-face visit.

Q: Why are large insurers opposed to the Medicare proposal?

A: The proposal would limit billing for stable chronic patients, cutting a major recurring revenue stream that insurers have built around continuous data collection.

Q: How does RPM generate profit for insurers?

A: Each transmitted data point can be billed under specific codes, and the aggregated data feeds analytics platforms that are sold back to providers and employers.

Q: What impact would the Medicare changes have on patients?

A: Patients with stable chronic conditions could lose continuous monitoring, potentially increasing the risk of untracked deterioration and hospitalisation.

Q: Are there alternatives to the proprietary RPM platforms?

A: Open-source and neutral RPM solutions exist, but they lack the data-integration and analytics capabilities that large insurers have built into their own platforms.